BEUDAMED
    2,466 results · 20ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 3 ×

    System, Test, Her-2/Neu, Ihc

    FDA Pre-Market Approval
    FDA Class 3 ·PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody

    System, Test, Her-2/Neu, Ihc

    FDA Pre-Market Approval
    FDA Class 3 ·PATHWAY anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody

    Transcatheter Septal Occluder

    FDA Pre-Market Approval
    FDA Class 3 ·GORE HELEX SEPTAL OCCLUDER

    System, Test, Her-2/Neu, Ihc

    FDA Pre-Market Approval
    FDA Class 3 ·BOND ORACLE HER2 IHC SYSTEM

    Transcatheter Septal Occluder

    FDA Pre-Market Approval
    FDA Class 3 ·GORE CARDIOFORM Septal Occluder

    System, Test, Her-2/Neu, Ihc

    FDA Pre-Market Approval
    FDA Class 3 ·Bond™ Oracle™ HER2 IHC System

    Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1

    FDA Pre-Market Approval
    FDA Class 3 ·PD-L1 IHC 22C3 PHARMDX

    System, Test, Her-2/Neu, Ihc

    FDA Pre-Market Approval
    FDA Class 3 ·BOND ORACLE HER2 IHC SYSTEM

    Immunohistochemistry Assay, Antibody, Ki-67

    FDA Pre-Market Approval
    FDA Class 3 ·Ki-67 IHC pharmDx

    Applicator, Hyperthermia, Superficial, Rf/Microwave

    FDA Pre-Market Approval
    FDA Class 3 ·HYPERTHERMIA SYSTEM 100 A

    Controller, Closed-Loop Blood Glucose

    FDA Pre-Market Approval
    FDA Class 3 ·BIOSTATOR GLUCOSE CONTROLLER

    Applicator, Hyperthermia, Superficial, Rf/Microwave

    FDA Pre-Market Approval
    FDA Class 3 ·HYPERTHERMIA SYSTEM 100 A

    Controller, Closed-Loop Blood Glucose

    FDA Pre-Market Approval
    FDA Class 3 ·BIOSTATOR GCIIS

    Electrode, Stabilized Epidural Spinal

    FDA Pre-Market Approval
    FDA Class 3 ·SPINAL EPIDURAL ELECTRODE FOR P.E.N.S. MODEL E-355

    Controller, Closed-Loop Blood Glucose

    FDA Pre-Market Approval
    FDA Class 3 ·BIOSTATOR GLUCOSE CONTROLLER

    Controller, Closed-Loop Blood Glucose

    FDA Pre-Market Approval
    FDA Class 3 ·BIOSTATOR GCIIS

    Controller, Closed-Loop Blood Glucose

    FDA Pre-Market Approval
    FDA Class 3 ·BIOSTATOR GCIIS

    Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1

    FDA Pre-Market Approval
    FDA Class 3 ·PD-L1 IHC 28-8 PHARMDX (Melanoma Indication)

    Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1

    FDA Pre-Market Approval
    FDA Class 3 ·PD-L1 IHC 22C3 pharmDx

    Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1

    FDA Pre-Market Approval
    FDA Class 3 ·PD L1 IHC 22C3 pharmDx